Frazier Life Sciences X, L.P.

Insider Reports History

Entity
Company
Location
601 Union Street, Suite 3200, Two Union Square, Seattle, WA
Signature
Frazier Life Sciences X, L.P., By: FHMLS X, L.P., its general partner, By: FHMLS X, L.L.C., its general partner, By: /s/ Steve R. Bailey, Chief Financial Officer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Frazier Life Sciences X, L.P.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
HilleVax, Inc. 10%+ Owner Common Stock 8.54M $126M $14.73 Apr 4, 2024 Direct
MBX Biosciences, Inc. 10%+ Owner Common Stock 4.55M Sep 16, 2024 Direct
MBX Biosciences, Inc. 10%+ Owner Series A Convertible Preferred Stock 0 Sep 16, 2024 Direct
MBX Biosciences, Inc. 10%+ Owner Series B Convertible Preferred Stock 0 Sep 16, 2024 Direct

Insider Reports Filed by Frazier Life Sciences X, L.P.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MBX MBX Biosciences, Inc. Sep 16, 2024 4 $10M 4 Sep 17, 2024 10%+ Owner
MBX MBX Biosciences, Inc. Sep 12, 2024 0 $0 3 Sep 12, 2024 10%+ Owner
HLVX HilleVax, Inc. Apr 4, 2024 0 $0 4/A May 31, 2024 10%+ Owner
HLVX HilleVax, Inc. Apr 4, 2024 1 $128K 4 Apr 8, 2024 10%+ Owner
HLVX HilleVax, Inc. May 3, 2022 3 $67.2M 4 May 3, 2022 10%+ Owner
HLVX HilleVax, Inc. Apr 28, 2022 0 $0 3 Apr 28, 2022 10%+ Owner